ECSP088287A - Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma - Google Patents
Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asmaInfo
- Publication number
- ECSP088287A ECSP088287A EC2008008287A ECSP088287A ECSP088287A EC SP088287 A ECSP088287 A EC SP088287A EC 2008008287 A EC2008008287 A EC 2008008287A EC SP088287 A ECSP088287 A EC SP088287A EC SP088287 A ECSP088287 A EC SP088287A
- Authority
- EC
- Ecuador
- Prior art keywords
- copd
- asthma
- compounds
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención provee composiciones farmacéuticas que comprenden un glucocorticosteroide y un compuesto de la fórmula: en donde m, R1, R2, R3 y R4 tienen las definiciones indicadas en la descripción, y su uso en terapia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0501896 | 2005-08-26 | ||
SE0601220 | 2006-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088287A true ECSP088287A (es) | 2008-04-28 |
Family
ID=37771856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008287A ECSP088287A (es) | 2005-08-26 | 2008-03-17 | Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090215732A1 (es) |
EP (1) | EP1922074B1 (es) |
JP (1) | JP2009506028A (es) |
KR (1) | KR20080038361A (es) |
AR (1) | AR055614A1 (es) |
AT (1) | ATE457731T1 (es) |
AU (2) | AU2006282121B2 (es) |
BR (1) | BRPI0615110A2 (es) |
CA (1) | CA2620847A1 (es) |
DE (1) | DE602006012332D1 (es) |
EC (1) | ECSP088287A (es) |
HK (1) | HK1116095A1 (es) |
IL (2) | IL189195A0 (es) |
MX (1) | MX2008002321A (es) |
NO (1) | NO20081480L (es) |
RU (1) | RU2414222C2 (es) |
TW (1) | TW200744612A (es) |
UY (1) | UY29760A1 (es) |
WO (1) | WO2007024182A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200738634A (en) * | 2005-08-02 | 2007-10-16 | Astrazeneca Ab | New salt |
EP2125728A4 (en) * | 2007-02-23 | 2011-06-22 | Astrazeneca Ab | NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA |
WO2008103126A1 (en) * | 2007-02-23 | 2008-08-28 | Astrazeneca Ab | Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
WO2009142588A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) a chemokine receptor 1 (ccr1) antagonist and (b) glucocorticoid receptor modulator |
GB0811099D0 (en) * | 2008-06-17 | 2008-07-23 | Astrazeneca Ab | New combination 376 |
SI2765994T1 (sl) | 2011-10-11 | 2019-02-28 | Chiesi Farmaceutici S.P.A. | Kristalni mikrodelci beta-agonista, obloženi z maščobno kislino |
RU2504382C1 (ru) * | 2012-06-13 | 2014-01-20 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
JP2023536815A (ja) * | 2020-07-28 | 2023-08-30 | スサヴィオン バイオサイエンシーズ インコーポレイテッド | 好中球駆動性炎症性病変の治療方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3994974A (en) * | 1972-02-05 | 1976-11-30 | Yamanouchi Pharmaceutical Co., Ltd. | α-Aminomethylbenzyl alcohol derivatives |
SE378109B (es) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
ES2165768B1 (es) * | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
AR028948A1 (es) * | 2000-06-20 | 2003-05-28 | Astrazeneca Ab | Compuestos novedosos |
JP2004516238A (ja) * | 2000-06-21 | 2004-06-03 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | ケモカイン受容体活性調節剤としてのn−ウレイドアルキル−ピペリジン |
GB0029562D0 (en) * | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
AR033290A1 (es) * | 2001-04-30 | 2003-12-10 | Glaxo Group Ltd | Derivados antiinflamatorios de androstano |
US20030229058A1 (en) * | 2001-11-13 | 2003-12-11 | Moran Edmund J. | Aryl aniline beta2 adrenergic receptor agonists |
SE0104251D0 (sv) * | 2001-12-14 | 2001-12-14 | Astrazeneca Ab | Novel compounds |
GB0207436D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
US20060183731A1 (en) * | 2003-07-15 | 2006-08-17 | Min Ge | 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
-
2006
- 2006-08-16 TW TW095130105A patent/TW200744612A/zh unknown
- 2006-08-22 UY UY29760A patent/UY29760A1/es not_active Application Discontinuation
- 2006-08-24 EP EP06769626A patent/EP1922074B1/en active Active
- 2006-08-24 CA CA002620847A patent/CA2620847A1/en not_active Abandoned
- 2006-08-24 JP JP2008527874A patent/JP2009506028A/ja active Pending
- 2006-08-24 BR BRPI0615110-8A patent/BRPI0615110A2/pt not_active IP Right Cessation
- 2006-08-24 AT AT06769626T patent/ATE457731T1/de not_active IP Right Cessation
- 2006-08-24 KR KR1020087004512A patent/KR20080038361A/ko not_active Application Discontinuation
- 2006-08-24 MX MX2008002321A patent/MX2008002321A/es active IP Right Grant
- 2006-08-24 AU AU2006282121A patent/AU2006282121B2/en not_active Ceased
- 2006-08-24 US US12/064,864 patent/US20090215732A1/en not_active Abandoned
- 2006-08-24 DE DE602006012332T patent/DE602006012332D1/de active Active
- 2006-08-24 RU RU2008108175/04A patent/RU2414222C2/ru not_active IP Right Cessation
- 2006-08-24 WO PCT/SE2006/000970 patent/WO2007024182A1/en active Application Filing
- 2006-08-25 AR ARP060103714A patent/AR055614A1/es unknown
-
2008
- 2008-02-03 IL IL189195A patent/IL189195A0/en unknown
- 2008-03-17 EC EC2008008287A patent/ECSP088287A/es unknown
- 2008-03-26 NO NO20081480A patent/NO20081480L/no not_active Application Discontinuation
- 2008-10-28 HK HK08111844.7A patent/HK1116095A1/xx not_active IP Right Cessation
-
2009
- 2009-05-27 IL IL199022A patent/IL199022A0/en unknown
- 2009-07-21 AU AU2009202925A patent/AU2009202925B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
MX2008002321A (es) | 2008-03-14 |
EP1922074A1 (en) | 2008-05-21 |
IL199022A0 (en) | 2010-02-17 |
BRPI0615110A2 (pt) | 2011-05-03 |
HK1116095A1 (en) | 2008-12-19 |
DE602006012332D1 (de) | 2010-04-01 |
JP2009506028A (ja) | 2009-02-12 |
US20090215732A1 (en) | 2009-08-27 |
EP1922074B1 (en) | 2010-02-17 |
AU2009202925B2 (en) | 2011-04-28 |
TW200744612A (en) | 2007-12-16 |
NO20081480L (no) | 2008-05-16 |
RU2414222C2 (ru) | 2011-03-20 |
ATE457731T1 (de) | 2010-03-15 |
IL189195A0 (en) | 2008-08-07 |
WO2007024182A1 (en) | 2007-03-01 |
AU2006282121A1 (en) | 2007-03-01 |
AU2006282121B2 (en) | 2009-12-24 |
AU2009202925A1 (en) | 2009-08-06 |
CA2620847A1 (en) | 2007-03-01 |
AR055614A1 (es) | 2007-08-29 |
RU2008108175A (ru) | 2009-10-10 |
KR20080038361A (ko) | 2008-05-06 |
UY29760A1 (es) | 2007-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088287A (es) | Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma | |
ECSP055774A (es) | Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica | |
UY29506A1 (es) | Nuevas formas cristalinas de bromuro de tiotropio | |
CY1117571T1 (el) | Συνδυασμος αντιχολινεργικων και ανταγωνιστων υποδοχεα λευκοτριενιου για την αγωγη αναπνευστικων νοσηματων | |
UY31686A1 (es) | Nueva dosificacion y formulacion | |
CY1121853T1 (el) | Συνδυαστικη θεραπεια για την αγωγη του διαβητη | |
CR9832A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
AR047386A1 (es) | Uso de pteridinas sustituidas para el tratamiento de enfermedades de las vias respiratorias | |
UY31687A1 (es) | Nueva dosificacion y formulacion | |
ECSP10010265A (es) | Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8 dihidro-9h-purin-9-il)propil](3-morfolin-4 ilpropil)amino]metil}fenil) | |
CL2011002787A1 (es) | Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica. | |
ATE421325T1 (de) | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen | |
CY1114665T1 (el) | Αναστολεις p38 map κινασης | |
DK2380584T3 (da) | Immunstimulerende fremgangsmåde | |
UY31526A1 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
ECSP088329A (es) | Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8 | |
CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
NO20070651L (no) | Sammensetninger av statiner med bronkodilatorer | |
ECSP066544A (es) | Nuevas sales de tiotropio, procedimientos para su preparación, así como formulaciones medicamentosas que las contienen | |
ECSP066770A (es) | Nuevos ésteres de quinuclidina cuaternizados | |
DE602005019416D1 (de) | Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid | |
CY1115384T1 (el) | Αντι-φλεγμονωδης συνθεση | |
CL2006003449A1 (es) | Compuestos derivados de n-(fluoro-pirazinil)-fenilsulfonamidas; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del asma. | |
UY30935A1 (es) | Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones. |